|
|
|
题名
|
作者
|
年代
|
出处
|
被引量
|
| 1 | Assessment of critical values policies in Italian institutions: comparison with the US situation 显示文摘 | Piva E Sciacovelli L Laposata M | 2010 | Clin Chem Lab Med2010，48，46： | 1 |
| 2 | Effects of alcohol on hemostasis 显示文摘 | Salem RO Laposata M | 2005 | Am J Clin Pathol2005，123，1： | 1 |
| 3 | “Pre-pre”and”post-post”analytical error:high-incidence patient safety hazardsinvolving the clinical laboratory显示文摘 | Laposata M Dighe A | 2007 | Clin Chem Lab Med2007，45，6： | 1 |
| 4 | The clinical use and laboratory monitoring of low-molecular-weight heparin, danaparoid, hirudin and related compounds, and argatroban 显示文摘 | Laposata M Green D Van Cott EM | 2008 | Arch Pathol Lab Med2008，122，： | 1 |
| 5 | Assessment of critical values policies in Italian institutions:com+ parison with the US situation 显示文摘 | Piva E Sciacovelli L Laposata M | 2010 | Clin Chem Lab Med2010，48，4： | 1 |
| 6 | Labo- ratory diagnosis of dysfibrinogenemia 显示文摘 | CUNNINGHAM M T BRANDT J T LAPOSATA M | 2002 | Arch Pathol Lab Med2002，126，4： | 1 |
| 7 | Patient-specific narrative interpretation of complex clinical laboratory evaluations:Who is competent to provide them?显示文摘 | Laposata M | 2004 | Clin Chem2004，50，3： | 1 |
| 8 | The identification and man- agement of heparin-induced thrombocytopenia in the vascular patient 显示文摘 | Lamuraglia GM Houbballah R Laposata M | 2012 | J Vasc Surg2012，55，2： | 1 |
| 9 | The clinical use and laboratory monitoring of low molecular weight heparin,danaparoid,hirudin and related compounds,and argatroban显示文摘 | Laposata M Green D Van Cott E M | 1998 | Arch Pathol Lab Med1998，122，： | 1 |
| 10 | Assessment of critical val- ues policies in Italian institutions:comparison with the US situation 显示文摘 | Piva E Sciacovelli L Laposata M | 2010 | Clin Chem Lab Med2010，48，4： | 1 |
| 11 | Fatty acid ethyl esters:ethanol metabolites which mediate ethanol-induced organ damage and serve as markers of ethanol intake显示文摘 | LAPOSATA M | | 0，，05： | 1 |
| 12 | Fatty acid ethyl esters:toxic non-oxidative metabolites of ethanol and markers of ethanol intake显示文摘 | Best C A Laposata M | 2003 | Frontiers in Bioscience2003，8，： | 1 |
| 13 | Fatty acid ethyl esters:non-oxidative metabolites of ethanol显示文摘 | LAPOSATA M SZCZEPIORKOWSKI Z M BROWN J E | | 0，，2： | 1 |
| 14 | Prothrombin gene mutation G20210A,homocysteine,antiphospholipid antibodies and other hypercoagulable states in ocular thrombosis显示文摘 | van Cott EM Laposata M Hartnett ME | 2004 | Blood Coagul Fibrinolysis2004，15，5： | 1 |
| 15 | The hydrolysis of fatty acid ethyl esters in low-density lipoproteins by red blood cells,white blood cells and platelets显示文摘 | SAGHIR M BLODGET E LAPOSATA M | | 0，，02： | 1 |
| 16 | Assessment of critical values policies in Italian institutions: comparison with the US situation显示文摘 | Elisa Piva Laura Sciacovelli Michael Laposata Mario Plebani | 2010 | Clinical Chemistry and Laboratory Medicine2010，，4： | 1 |
| 17 | Metabolism of ethanol by human-brain to fatty-acid ethyl-esters显示文摘 | LAPOSATA E A SCHERRER D E MAZOW C | | 0，，： | 1 |
| 18 | A 40-year-old woman with epistaxis, hematemesis, and al-tered mental status显示文摘 | LAPOSATA M VAN COTT E M LEV M H | 2007 | N Engl J Med2007，356，： | 1 |
| 19 | Fatty acid ethyl esters:recent observations显示文摘 | LAPOSATA M HASABA A CATHERINE A B | | 0，，2： | 1 |
| 20 | “Pre-pre” and “post-post” analytical error: high-incidence patient safety hazards involving the clinical laboratory显示文摘 | Michael Laposata Anand Dighe | 2007 | Clinical Chemical Laboratory Medicine2007，，6： | 1 |
您所在的机构暂未开通此部分的功能，请联系管理员